Form 4: VolitionRx COO's Tax Withholding on RSU Vesting

VolitionRx's Chief Operating Officer, Gaetan Michel, had 12,333 shares withheld by the company to cover tax obligations related to the vesting of 24,666 restricted stock units.

Summary

• Gaetan Michel, Chief Operating Officer of VolitionRx Ltd. (VNRX), reported a change in beneficial ownership.
• On October 4, 2025, 12,333 shares of common stock were disposed of by the company on behalf of Mr. Michel.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations upon the settlement of 24,666 restricted stock units.
• The transaction price for the disposed shares was $0.648 per share.
• No shares were sold by either the reporting person or VolitionRx in this transaction; it was solely for tax purposes.
• Following this transaction, Mr. Michel beneficially owns 256,746 shares of VolitionRx common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction related to executive compensation and tax obligations, not indicative of a change in company fundamentals or management's view on the stock.

Positives

• The vesting of 24,666 restricted stock units indicates a component of executive compensation being realized, which is a positive for the Chief Operating Officer.

Negatives

• A reduction of 12,333 shares in beneficial ownership due to tax withholding, although a standard practice, represents a decrease in the officer's direct equity stake.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units and the subsequent tax withholding. Such events are common across all industries for publicly traded companies that utilize equity-based compensation plans.

Related Party Transactions

• The transaction involves the company (VolitionRx) withholding shares from its Chief Operating Officer (Gaetan Michel) to cover tax liabilities arising from the settlement of restricted stock units, which is a standard compensation-related dealing between an executive and the company.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine compensation event and not a market sale by the officer. The number of shares withheld is a small fraction of the company's outstanding shares.
• Employees: This transaction highlights the company's equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction related to executive compensation (RSU vesting and tax withholding). It does not provide any new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining the existing investment thesis.

Keywords

VNRX, VolitionRx, Form 4, Insider Transaction, RSU, Restricted Stock Units, Tax Withholding, Gaetan Michel, Executive Compensation